Product Details

Sandoz Guanfacine XR

Guanfacine
3 mg
ER Tablet


DIN/PIN/NPN

02563207

Manufacturer

Sandoz Canada Inc.

Formulary Listing Date

2026-05-29  

Unit Price

1.1019

Amount MOH Pays

1.1019

Coverage Status

Limited Use Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

C02AC02

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02409127 Intuniv XR 4.4075 1.1019
02523744 Apo-Guanfacine XR 1.1019 1.1019
02523574 Jamp Guanfacine XR 1.1019 1.1019
02563207 Sandoz Guanfacine XR 1.1019 1.1019
 

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
540 1 year

For the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 to 17 years who meet the following criteria:

(i) As adjunctive therapy to psychostimulants; OR

(ii) As monotherapy in patients who have significant intolerance to psychostimulants AND who have had an inadequate response to either atomoxetine or other non-stimulant alternative(s).

 

Requirements


EAP Criteria

  NO

Product Monograph

View Monograph